At a glance
- Originator Nisshin Pharma
- Class Antiarrhythmics; Cardiotonics; Vasodilators
- Mechanism of Action Calcium channel antagonists; Phosphoric diester hydrolase inhibitors; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Heart failure
Most Recent Events
- 11 Sep 2000 Discontinued-Preclinical for Arrhythmias in Japan (IV)
- 11 Sep 2000 Discontinued-Preclinical for Arrhythmias in Japan (PO)
- 11 Sep 2000 Discontinued-Preclinical for Congestive heart failure in Japan (IV)